Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Intelligent Bio Solutions Inc. (INBS)

NCM · Medical Devices

$1.59-0.13 (-7.33%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$3.8M
P/E (TTM)
EPS
$-10.81
Div Yield
52W Range
$1.52–$24.90
Beta
4.17

Company overview

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.

Peers in Medical Devices

All in industry →

Recent press releases

Intelligent Bio Solutions Inc. has not issued a press release in this window.

SEC filings

All filings →

Intelligent Bio Solutions Inc. has not filed an SEC document in this window.

Intelligent Bio Solutions Inc. has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for Intelligent Bio Solutions Inc. in this window.

People at Intelligent Bio Solutions Inc.

All people →

Quarterly financials

Full financials →
Revenue trend
12/24
$388.3K
NI -$2.2M
03/25
$728.9K
NI -$2.5M
09/25
$1.1M
NI -$3.0M
RevenueNI = Net Income
EPS trend (diluted)
Latest: $-0.35
Prior: $-0.44
Revenue sparkline